Position in MNPR
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$3,458,290
New position
Shares Held
63,119
first reported quarter
Ownership
0.942%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Walleye Capital LLC holds $278,324,471 across 103 Biotechnology names. MNPR ranks #26 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMRN |
Biomarin Pharmaceutical Inc
|
364,246 | $20,576,256 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
228,593 | $16,975,316 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
87,365 | $16,516,353 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
30,752 | $13,731,998 | |
| 5 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
153,585 | $12,888,853 | |
| 6 | CELC |
Celcuity Inc.
|
105,688 | $12,063,228 | |
| 7 | INSM |
INSMED Inc
|
71,819 | $11,743,842 | |
| 8 | SNDX |
Syndax Pharmaceuticals Inc
|
384,973 | $8,992,969 |
All Filings in MNPR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,458,290 | 63,119 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||